RecruitingNot ApplicableNCT06514014

Transition From Donor Milk: a Feasibility Study


Sponsor

Augusta University

Enrollment

20 participants

Start Date

May 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Preterm and very low birth weight (VLBW, \< 1,500g) infants who receive donor human milk (DHM) often experience slow postnatal growth and no clinical data is available to guide the duration of DHM for preterm infants. The investigators hypothesize that transitioning from DHM to preterm infant formula after the first month of life is both safe and conveys improved weight and length gains and fat free mass accumulation.


Eligibility

Min Age: 28 Days

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Preterm Infant Formula for people with nutrition, healthy and preterm birth. The study is currently recruiting participants at 1 location. People eligible for this study include aged 28 Days and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTPreterm Infant Formula

Transition from donor human milk to preterm infant formula


Locations(1)

Wellstar-MCG

Augusta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06514014


Related Trials